Status:
COMPLETED
Cerebellar tDCS and Balance Training in PwMS
Lead Sponsor:
University of Iowa
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Many people with multiple sclerosis (PwMS) have decreased balance and postural control, gait deficits, and a high frequency of falls. High fall rates and mobility impairments pose a significant risk t...
Eligibility Criteria
Inclusion
- medically diagnosed with relapsing-remitting multiple sclerosis
- 18-70 years of age
- moderate disability (score of 2-6 on the Patient Determined Disease Scale)
- self-reported differences in function between legs, have fallen within the last year
- able to walk for 6 mins, and not taking any psychoactive medication.
Exclusion
- relapse within the last 60 days
- have changed disease modifying medications in the last 45 days
- are currently pregnant
- have a concurrent neurological or neuromuscular disease
- have been hospitalized within the last 90 days
- have any contraindications for the tDCS device (i.e., pacemakers or metal implants)
- are unable to understand/sign the consent form.
Key Trial Info
Start Date :
September 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 16 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04391023
Start Date
September 26 2022
End Date
July 16 2023
Last Update
June 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242